Management of Severe Hyponatremia and Dyspnea in Cancer Patients

Immediate Priorities

The American Thoracic Society recommends that a sodium level of 115 mEq/L is life-threatening and requires urgent intervention to prevent seizures, coma, and death 1
The European Society for Medical Oncology suggests that SIADH is present in 10-45% of small cell lung cancer cases and 1% of other lung cancers, and hyponatremia in cancer patients is associated with shortened survival 1
At sodium <120 mEq/L, life-threatening manifestations including altered mental status, seizures, and respiratory compromise may occur, according to the American College of Chest Physicians 1
The recent family death and associated stress may have exacerbated the syndrome, but the underlying paraneoplastic process is the primary driver, as stated by the American Thoracic Society 1

The British Thoracic Society recommends performing urgent diagnostic workup including complete blood count, electrolytes, arterial blood gas, oxygen saturation, chest X-ray, and ECG to assess irregular breathing pattern 2, 3
The American College of Chest Physicians suggests checking oxygen saturation immediately - if SpO2 <85%, initiate oxygen therapy urgently 5

The European Society for Medical Oncology recommends positioning the patient optimally (elevated head of bed, coachman's seat position) as a non-pharmacological intervention for dyspnea 2, 3
The American Thoracic Society suggests using cooling measures - handheld fan directed at face, open windows - as a non-pharmacological intervention for dyspnea 2, 3
The American College of Chest Physicians recommends providing supplemental oxygen only if hypoxemic (SpO2 <92%) - oxygen does not help non-hypoxemic dyspnea 2, 7
The European Society for Medical Oncology suggests that opioids are the only pharmacological agents with sufficient evidence for dyspnea palliation, with a recommended starting dose of morphine 2.5-5 mg PO every 4 hours, or 1-2 mg IV/SC every 2-4 hours 2, 3, 6

The National Comprehensive Cancer Network recommends ensuring goals of care are clearly established, given the patient's advanced cancer status (post-CTRT, on follow-up) 9, 8, 10
The American Thoracic Society suggests that palliative care consultation is appropriate for symptom management expertise, particularly for refractory dyspnea 9, 8, 4